Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
Appropriate course of action for following pt: immigrant from SE Asia, tired for past mo, weight loss, fever and night sweats 2 weeks ago, cough with green sputum and blood, CXR with infiltrate in upper lobe; prelim dx of pulm TB
|
hospitalize and start tx with INH, rifampin, pyrazinamide and ethambutol
|
|
T or F about INH? flushing, palpitations, sweating, dyspnea after ingesting tyramine foods
|
true; inhibits MAO type A
|
|
T or F about INH? persons from SE Asia require lower maintanance doses
|
false; fast acetylators like Native Ams and Asians require higher doses
|
|
T or F about INH? should take pyridoxine daily
|
TRUE
|
|
T or F about INH? sx of peripheral neuritis may occur
|
TRUE
|
|
T or F about INH? risk of hepatitis is less than 2%
|
true; 0.3% in 21-35 yo and > 2% in 50+ yo
|
|
Which antimycobacterial agent can inhibit the action of BCPs?
|
rifampin, by inducing formation of P450 which increases rate of elim of anticoags, ketoconazole, methadone and steroids
|
|
Mech of high-level INH resistance in TB
|
reduced expression of katG gene
|
|
Optimal management of AIDS pt with CD4 = 100, persistent fever and weight loss, dx invasive MAC
|
clarithromycin (or erythromycin), ethambutol and rifabutin (not rifampin due to drug interactions)
|
|
If pt has pulm TB (resistance < 4%) is tx with INH, rifampin and pyrazinamide for 2 mo; then pyrazinamide is stopped, for how long due you continue the other drugs?
|
4 mo; if pyrazinamide weren't given at all, INH and rifampin should be given for 9 mo
|
|
Drug used prophylactically in contacts of kids with HiB and meningococcal and staph carrier states (but highly resistant strains may be selected during treatment)
|
rifampin
|
|
T or F about antitubercular drugs? antimycobact actions of streptomycin involve inhibition of arabinosyl transferase
|
false; this occurs with ethambutol
|
|
T or F about antitubercular drugs? cross resistance of M TB to INH and pyrazinamide is common
|
false; because these have different MOAs
|
|
T or F about antitubercular drugs? ocular toxicity of ethambutol is prevented by thiamine
|
false; ocular toxicity is dose dep and reversible with D/C
|
|
T or F about antitubercular drugs? pyrazinamide tx should be D/C immediately if hyperuricemia occurs
|
false; this is a uniform SE and not a reason to D/C tx
|
|
T or F about antitubercular drugs? Resistance to ethambutol involves mutations in emb gene
|
TRUE
|
|
Drug used in prophylaxis of bacteremia caused by MAC in AIDS pt
|
azithromycin (due to long half life)
|
|
Which antimycobacterial drug is most likely to cause loss of equil and auditory changes?
|
amikacin (aminoglycoside)
|
|
Meningitis prophylaxis in exposed patients
|
rifampin
|
|
Treatment for TB patients (think RIPE)
|
Rifampin, Isoniazid, Pyrazinamide, and Ethambutol
|
|
Common side effect of Rifampin
|
Red urine discoloration
|
|
Appropriate course of action for following pt: immigrant from SE Asia, tired for past mo, weight loss, fever and night sweats 2 weeks ago, cough with green sputum and blood, CXR with infiltrate in upper lobe; prelim dx of pulm TB
|
hospitalize and start tx with INH, rifampin, pyrazinamide and ethambutol
|
|
T or F about INH? flushing, palpitations, sweating, dyspnea after ingesting tyramine foods
|
true; inhibits MAO type A
|
|
T or F about INH? persons from SE Asia require lower maintanance doses
|
false; fast acetylators like Native Ams and Asians require higher doses
|
|
T or F about INH? should take pyridoxine daily
|
TRUE
|
|
T or F about INH? sx of peripheral neuritis may occur
|
TRUE
|
|
T or F about INH? risk of hepatitis is less than 2%
|
true; 0.3% in 21-35 yo and > 2% in 50+ yo
|
|
Which antimycobacterial agent can inhibit the action of BCPs?
|
rifampin, by inducing formation of P450 which increases rate of elim of anticoags, ketoconazole, methadone and steroids
|
|
Mech of high-level INH resistance in TB
|
reduced expression of katG gene
|
|
Optimal management of AIDS pt with CD4 = 100, persistent fever and weight loss, dx invasive MAC
|
clarithromycin (or erythromycin), ethambutol and rifabutin (not rifampin due to drug interactions)
|
|
If pt has pulm TB (resistance < 4%) is tx with INH, rifampin and pyrazinamide for 2 mo; then pyrazinamide is stopped, for how long due you continue the other drugs?
|
4 mo; if pyrazinamide weren't given at all, INH and rifampin should be given for 9 mo
|
|
Drug used prophylactically in contacts of kids with HiB and meningococcal and staph carrier states (but highly resistant strains may be selected during treatment)
|
rifampin
|
|
T or F about antitubercular drugs? antimycobact actions of streptomycin involve inhibition of arabinosyl transferase
|
false; this occurs with ethambutol
|
|
T or F about antitubercular drugs? cross resistance of M TB to INH and pyrazinamide is common
|
false; because these have different MOAs
|
|
T or F about antitubercular drugs? ocular toxicity of ethambutol is prevented by thiamine
|
false; ocular toxicity is dose dep and reversible with D/C
|
|
T or F about antitubercular drugs? pyrazinamide tx should be D/C immediately if hyperuricemia occurs
|
false; this is a uniform SE and not a reason to D/C tx
|
|
T or F about antitubercular drugs? Resistance to ethambutol involves mutations in emb gene
|
TRUE
|
|
Drug used in prophylaxis of bacteremia caused by MAC in AIDS pt
|
azithromycin (due to long half life)
|
|
Which antimycobacterial drug is most likely to cause loss of equil and auditory changes?
|
amikacin (aminoglycoside)
|
|
Meningitis prophylaxis in exposed patients
|
rifampin
|
|
Treatment for TB patients (think RIPE)
|
Rifampin, Isoniazid, Pyrazinamide, and Ethambutol
|
|
Common side effect of Rifampin
|
Red urine discoloration
|
|
Neurotoxicity with isoniazid (INH) prevented by
|
Administration of Vit. B6 (pyridoxine)
|
|
SE of INH
|
Peripheral neuritis and hepatitis
|
|
Drug of choice for leprosy
|
Dapsone, rifampin and clofazimine combination
|
|
MOA of rifampin
|
inhibits DNA-dep RNA polymerase (encoded by rpo)
|
|
drug used with vancomycin for MRSA and PRSP
|
rifampin
|
|
SEs of ethambutol
|
dose dep visual disturbances (decreased acuity, red-green blindness, optic neuritis and retinal damage)
|
|
MOA of dapsone
|
inhibition of folic acid synthesis
|
|
Drug used for leprosy that may cause skin discoloration (red-brown to black)
|
clofazimine
|